查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2152174

美國非處方（OTC）連續血糖監測設備市場規模、佔有率和趨勢分析報告：按用戶、應用、銷售管道和細分市場預測（2026-2033 年）

U.S. OTC Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By User, By Application, By Sales Channel, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

美國非處方（OTC）連續血糖監測（CGM）設備市場概述

預計到 2025 年，美國非處方 (OTC) 連續血糖監測 (CGM) 設備市場價值將達到 1.94 億美元，到 2026 年將成長至 2.072 億美元，到 2033 年將達到 4.035 億美元，2026 年至 2033 年的年複合成長率（CAGR）.6%。

生活方式和健康設備的日益普及，包括簡化糖尿病管理的持續血糖監測儀（CGM），以及穿戴式健康工具獲取管道的日益便捷，正在推動市場需求。到2025年，近20%的美國人計劃使用穿戴式裝置來實現其健康目標。根據雅培公司的報告，美國三分之二的Lingo會員已經開始使用非處方（OTC）CGM，以便即時做出更健康的決策。

預計未來5到10年內，美國老年族群的血糖監測普及率將達50%。老年人口的成長和久坐不動的生活方式加劇了疾病負擔，因此亟需開發先進的監測解決方案，例如持續血糖監測（CGM）。此外，隨著醫療基礎設施的完善以及無需處方箋即可透過電子商務購買CGM設備，CGM的普及率將進一步提高。感測器精度的提升、應用程式的整合以及數據共用等技術進步，正在進一步推動都市區和郊區市場的成長。

到2025年，美國將有約3,800萬成年人被診斷出患有糖尿病，佔成年人口總數的11.5%。此外，該國約有9,700萬成年人處於糖尿病前期。肥胖和久坐的生活方式是導致糖尿病高發生率的主要因素。隨著第二型糖尿病病例持續激增以及人們對早期診斷意識的提高，預計美國對非處方（OTC）連續血糖監測（CGM）設備的需求將會增加。

新推出的非處方（OTC）持續血糖監測（CGM）設備推薦用於未接受胰島素治療的第二型糖尿病患者。對於第2型糖尿病患者，處方箋CGM不在醫療保險範圍內，因此非處方產品成為有效的替代方案。非處方CGM價格實惠，無需處方箋即可購買。雖然非處方CGM不在醫療保險範圍內，但通常接受透過健康援助計劃/彈性支出帳戶（HAS/FSA）支付。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國非處方CGM設備市場：影響因素、趨勢與市場規模

  • 市場概況及未來展望
  • 市場規模和成長前景
  • 市場動態
  • 美國非處方（OTC）連續血糖監測設備市場分析工具

第4章：美國非處方（OTC）連續血糖監測設備市場：基於使用者的估算和趨勢分析

  • 美國非處方（OTC）連續血糖監測（CGM）設備市場用戶變化分析。
  • 美國非處方連續血糖監測（CGM）設備市場規模及趨勢分析（按使用者分類，2024-2033 年）
  • 非糖尿病患者
  • 糖尿病前期
  • 糖尿病患者

第5章：美國非處方（OTC）連續血糖監測設備市場：按應用分類的估算和趨勢分析

  • 基於應用的美國非處方連續血糖監測（CGM）設備市場市場分析。
  • 美國非處方連續血糖監測（CGM）設備市場規模及趨勢分析（按應用領域分類，2024-2033 年）
  • 生活方式與健康
  • 糖尿病監測

第6章：美國非處方（OTC）連續血糖監測設備市場：依銷售管道分類的估算與趨勢分析

  • 美國非處方（OTC）連續血糖監測設備市場：按銷售管道分類的趨勢分析
  • 美國非處方（OTC）連續血糖監測設備市場：按銷售管道分類的市場規模和趨勢分析，2025-2033年
  • 企業網站
  • 零售

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Abbott Laboratories
    • Dexcom Inc.
Product Code: GVR-4-68040-717-8

U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Summary

The U.S. OTC continuous glucose monitoring (CGM) devices market size was valued at USD 194.0 million in 2025 and is projected to grow from USD 207.2 million in 2026 to USD 403.5 million by 2033, at a CAGR of 9.6% from 2026 to 2033. The rising adoption of lifestyle wellness devices, including CGM to ease diabetes management, and easy access to wearable health tools, are fueling demand. In 2025, nearly 20% of Americans planned to use wearable devices to achieve their health goals, while Abbott reported that two out of three U.S. Lingo members began using an OTC CGM to make healthier decisions in real time.

In the coming 5 to 10 years, the adoption rate is expected to reach 50% among elderly Americans. The growing geriatric population and sedentary lifestyles contribute to the disease burden, imposing the development of advanced monitoring solutions such as CGM. Furthermore, expanding healthcare infrastructure and distribution of CGM devices through e-commerce without a prescription would ease accessibility. Technological advancements like sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.

As of 2025, nearly 38 million American adults are diagnosed with diabetes, marking 11.5% of the total adult population in the U.S. Furthermore, around 97 million adults are prediabetic in the country. Obesity and a sedentary lifestyle are the major contributing factors to the prevalence of diabetes. Continued surge in type 2 diabetes cases and growing awareness of early diagnoses are likely to boost the demand for OTC CGM devices in the U.S.

Newly introduced OTC CGM devices are suggested to be used by type 2 diabetes that are not on insulin. As type 2 diabetes does not get the insurance for prescription CGM, OTC comes in as a help. OTC CGM sells at an affordable rate and without a prescription. Although the OTC CGMs are not covered by insurance, the HAS/FSA funds are generally accepted.

U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. OTC continuous glucose monitoring (CGM) devices market report based on user, application, and sales channel.

  • User Outlook (Revenue, USD Million, 2021 - 2033)
    • Non-diabetic
    • Prediabetic
    • Diabetic
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Lifestyle Wellness
    • Diabetes Monitoring
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
    • Company Website
    • Retailers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. OTC CGM Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. OTC CGM Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. OTC CGM Devices Market: User Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market User Movement Analysis
  • 4.3. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Size & Trend Analysis, by User, 2024 to 2033 (USD Million)
  • 4.4. Non-diabetic
    • 4.4.1. Non-diabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Prediabetic
    • 4.5.1. Prediabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Diabetic
    • 4.6.1. Diabetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. OTC CGM Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Application Movement Analysis
  • 5.3. U.S. OTC Continuous Glucose Monitoring (CGM) Devices Market Size & Trend Analysis, by Application, 2024 to 2033 (USD Million)
  • 5.4. Lifestyle Wellness
    • 5.4.1. Lifestyle wellness market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Diabetes Monitoring
    • 5.5.1. Diabetes monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. OTC CGM Devices Market: Sales Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. OTC Continuous Glucose Monitoring Devices Market Sales Channel Movement Analysis
  • 6.3. U.S. OTC Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Sales Channel, 2025 to 2033 (USD Million)
  • 6.4. Company Website
    • 6.4.1. Company website Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Retailers
    • 6.5.1. Retailers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Abbott Laboratories
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Dexcom Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. OTC continuous glucose monitoring devices by user, 2021 - 2033 (USD Million)
  • Table 4 U.S. OTC continuous glucose monitoring devices by application, 2021 - 2033 (USD Million)
  • Table 5 U.S. OTC continuous glucose monitoring devices by sales channel, 2021 - 2033 (USD Million)
  • Table 6 Participant's overview
  • Table 7 Financial performance
  • Table 8 Key companies undergoing expansions
  • Table 09 Key companies undergoing acquisitions
  • Table 10 Key companies undergoing collaborations
  • Table 11 Key companies launching new products
  • Table 12 Key companies undergoing partnerships
  • Table 13 Key companies undertaking other strategies

List of Figures

  • Fig.1 Information Procurement
  • Fig.2 Primary Research Pattern
  • Fig.3 Market Research Approaches
  • Fig.4 Value Chain-Based Sizing & Forecasting
  • Fig.5 Market Formulation & Validation
  • Fig.6 U.S. OTC CGM devices market segmentation
  • Fig.7 Market driver analysis (Current & future impact)
  • Fig.8 Market restraint analysis (Current & future impact)
  • Fig.9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig.10 Porter's Five Forces Analysis
  • Fig.11 U.S. OTC continuous glucose monitoring devices user outlook key takeaways (USD Million)
  • Fig.12 U.S. OTC continuous glucose monitoring devices market user movement analysis (USD Million), 2024 & 2033
  • Fig.13 Non-diabetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig.14 Prediabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig.15 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig.16 U.S. OTC continuous glucose monitoring devices application outlook key takeaways (USD Million)
  • Fig.17 U.S. OTC continuous glucose monitoring devices market application movement analysis (USD Million), 2024 & 2033
  • Fig.18 Lifestyle wellness market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig.19 Diabetes monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig.20 U.S. OTC continuous glucose monitoring devices sales channel outlook key takeaways (USD Million)
  • Fig.21 U.S. OTC continuous glucose monitoring devices sales channel analysis (USD Million), 2024 & 2033
  • Fig.22 Company website market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig.23 Retailers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig.24 Heat map analysis
  • Fig.25 Market participant categorization
  • Fig.26 U.S. OTC continuous glucose monitoring devices market share analysis, 2024
  • Fig.27 Strategy framework